Compare MEC & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEC | LAB |
|---|---|---|
| Founded | 1945 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 435.4M | 354.1M |
| IPO Year | 2019 | 2008 |
| Metric | MEC | LAB |
|---|---|---|
| Price | $21.64 | $0.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $24.33 | $1.35 |
| AVG Volume (30 Days) | 106.0K | ★ 2.9M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | $10.65 | N/A |
| Revenue Next Year | $8.66 | $2.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.99 | $0.87 |
| 52 Week High | $22.37 | $1.72 |
| Indicator | MEC | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 41.80 |
| Support Level | $17.20 | N/A |
| Resistance Level | $22.37 | $1.01 |
| Average True Range (ATR) | 0.89 | 0.06 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 98.68 | 15.25 |
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.